Curanex Pharmaceuticals Inc

Contributing Author

Recent Articles by Curanex Pharmaceuticals Inc

Oct-22	Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement CURX +14.39% GlobeNewswire
Sep-12	Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters CURX GlobeNewswire
Aug-27	Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering CURX +15.92% CURX +11.37% GlobeNewswire
Aug-26	Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering CURX GlobeNewswire